Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the company's French headquarters in Rueil-Malmaison near Paris, ...

Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body. It provides an ...

There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things.

The Global Burden of Disease (GBD) Study 2021 reported 44.84 million disability-adjusted life years (DALYs) because of skin and subcutaneous diseases. Researchers utilized data from the GBD Study 2021 ...

As if excess belly fat is not bad enough, researchers now say it brings a significantly higher risk of developing a chronic inflammatory skin disease. Researchers from King’s College London evaluated ...

(Reuters) -The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the Swiss drugmaker said on Tuesday. The twice-daily ...